Eton Pharmaceuticals, Inc. Balance Sheet
ETON|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Eton Pharmaceuticals, Inc. had $92M in total assets and $24M in shareholders' equity as of FY2025. Total debt was $22M against $26M in cash, resulting in a $4M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25.9M | $14.9M | $21.4M | $16.3M | $14.4M | $21.3M | $12.1M |
| Accounts Receivable | $11.8M | $5.4M | $3.4M | $1.9M | $5.5M | $48.0K | $473.0K |
| Inventory | $15.4M | $15.2M | $911.0K | $557.0K | $550.0K | $1.2M | $380.0K |
| Current Assets | $60.6M | $41.0M | $26.8M | $20.0M | $23.6M | $24.7M | $15.0M |
| PP&E (Net) | $326.0K | $34.0K | $58.0K | $72.0K | $115.0K | $811.0K | $1.1M |
| Total Assets | $92.1M | $76.1M | $31.7M | $25.0M | $27.5M | $26.3M | $17.1M |
| Current Liabilities | $38.5M | $19.9M | $16.2M | $6.5M | $4.6M | $3.8M | $2.0M |
| Total Debt | $21.8M | $29.8M | $0 | $5.4M | $5.3M | $6.5M | $4.5M |
| Shareholders' Equity | $24.4M | $13.1M | $15.7M | $15.7M | $10.6M | $26.3M | -$6.9M |